特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无 法看到我们的推送。 仪粉er们，今天是精品仪器类职位专辑 哦！ 仪器精英，热招职位 Ho t r e c r u itme n t p o siti o n s 销售类 安捷伦 销售工程师 全国有岗-面议 任 职 要 求 ： 硕 士 及 以 上 学 历 ， 制 药 、 食 品 、 环 境 、 化 学 、 生 物 、 材 料 等 相 关 专 业 ； 2025/2026届毕业生，熟练掌握色质谱学科基础理论，有相关产品使用经验；出色的人际交 往能力和沟通能力，团队合作能力强；有明确的自我提升意愿和目标，持续学习能力强。 智矩未来 生物分析仪器销售顾问 上海- 8k-13k ·12薪 任职要求： 大专及以上学历，生物、医学、化学等相关专业优先；具备良好的沟通能力和客户 服务意识，在生物仪器行业销售有三年工作经验者优先；熟悉生物仪器产品知识，能适应出差 工作；具有较强的学习能力与团队协作精神，能够承受一定工作压力。 北裕分析 销售员 兰州、云南、长春、西宁-面议 任职要求： 本科及以上学历，化学、环境、仪器仪表等 ...

Active Managers Add 25% to Short-Term Bond ReturnsETF Trends is now VettaFi. Read More --Investors seeking protection from geopolitical volatility and stubborn inflation in 2026 may find opportunity in short-term bonds, where active management has historically delivered returns 25% higher than passive strategies, according to Vontobel Asset Management.Research going back to the 1990s shows investors in short-term, high-quality corporate bonds typically earn total returns of 1.25 times their starting yield i ...

HYDERABAD, India, Feb. 5, 2026 /PRNewswire/ -- According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion in 2026 to reach USD 58.66 billion by 2031, at a CAGR of 11.87% during the forecast period (2026-2031). The market expansion is supported by the growing focus on precision medicine, increasing prevalence of chronic diseases, and rising demand for advanced analytical tools to understand complex biological systems.  Th ...

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25Feb 2, 2026 4:15 PM Eastern Standard Time# Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25Share--- SANTA CLARA, Calif.--([BUSINESS WIRE])--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.To join ...

特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无 法看到我们的推送。 仪粉er们，今天是精品仪器类职位专辑 哦！ 仪器精英，热招职位 Ho t r e c r u itme n t p o siti o n s 销售类 安捷伦 销售工程师 全国有岗-面议 任 职 要 求 ： 硕 士 及 以 上 学 历 ， 制 药 、 食 品 、 环 境 、 化 学 、 生 物 、 材 料 等 相 关 专 业 ； 2025/2026届毕业生，熟练掌握色质谱学科基础理论，有相关产品使用经验；出色的人际交 往能力和沟通能力，团队合作能力强；有明确的自我提升意愿和目标，持续学习能力强。 欧世盛 固定床销售经理 全国有岗- 15k-35k ·18薪 任职要求： 本科及以上学历，专业不限；擅长技术型销售，具有固定床在石油石化领域的销售 经验，和良好的市场分析判断能力；具有良好的学习能力、执行力、团队协作能力；可适应短 期出差。 安东帕 销售工程师 全国有岗-面议 销售工程师 北京- 12k-15k ·12薪 任职要求： 热爱销售工作，吃苦耐劳；理工科专业背景（物理、化学、材料类等 ...

摘要 ： "3i奖-优秀新品"二十年来，累计评选出年度优秀新品429台，质谱类以76台获奖位列第一。 高分辨质谱技术在很大程度上解决了传统质谱技术在蛋白质分析中面临灵敏度不足、分辨率有 限、通量低下三大瓶颈，能够实现复杂生物样本中数千种蛋白质组成解析、低丰度蛋白识别、 翻译后修饰（如磷酸化、糖基化）准确测定。 2011 年 赛 默 飞 推 出 Orbitrap El ite ， 将 扫 描 速 度 提 升 至 每 秒 12 张 高 分 辨 谱 图 。 2014 年 SCIEX的TripleTOF 6600系统则通过超快扫描技术实现了数据非依赖采集，使单次进样可定 量数千种蛋白质；该仪器也将代谢物鉴定从几百种扩展到数千种，覆盖了氨基酸、有机酸、脂 质 、 激 素 等 几 乎 所 有 代 谢 物 类 别 。 2018 年 SCIEX 的 M5 Microflow LC - OptiFlow™Turbo V源集成化高灵敏度质谱系统将纳流色谱与质谱联用，显著提高了蛋白质 序列覆盖率和修饰位点鉴定准确性。2019年赛默飞的Orbitrap Ecl ipse引入了实时搜索、智 能 碎 裂 等 AI 算 法 ， 将 质 谱 ...

Donny DBM/iStock via Getty Images The following segment was excerpted from the GreensKeeper Value Fund Q4 2025 Letter. Our top performer in 2025 was Alphabet Inc. (GOOG) +64.8%. Alphabet had a volatile year, with its shares finishing the year 120% above ...

Core Viewpoint - Prestige Consumer Healthcare (PBH) is currently viewed as a more attractive investment option compared to Agilent Technologies (A) for value investors, based on various financial metrics and analyst outlooks [3][6]. Valuation Metrics - PBH has a forward P/E ratio of 14.89, significantly lower than A's forward P/E of 23.38, indicating that PBH may be undervalued relative to A [5]. - The PEG ratio for PBH is 2.13, while A's PEG ratio is 4.02, suggesting that PBH offers better value when considering expected earnings growth [5]. - PBH's P/B ratio stands at 1.83, compared to A's P/B of 5.83, further supporting the notion that PBH is undervalued [6]. Analyst Ratings - PBH holds a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision activity, while A has a Zacks Rank of 3 (Hold), reflecting a less favorable outlook [3][6]. - Based on the combination of valuation metrics and analyst ratings, PBH is considered the superior value option at this time [6].

Agilent Technologies, Inc. (A), headquartered in Santa Clara, California, provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. Valued at $39.6 billion by market cap, the company offers electronic and bio-analytical measurement, semiconductor, and board testing. The global leader in analytical and clinical laboratory technologies is expected to announce its fiscal first-quarter earnings for 2026 in the near future. Ahead of the event, analysts expect A to ...

Core Insights - Organoid technology is a revolutionary model in life sciences, showing great potential in simulating human organ development, disease mechanism research, and drug development, but faces significant bottlenecks in scaling and standardization [1] - Current organoid research needs to move beyond traditional morphological observations to deeper functional analyses, particularly in assessing cellular energy metabolism, which is crucial for evaluating organoid viability, drug toxicity, and metabolic disease phenotypes [1] - The reliance on manual operations and animal-derived matrix gels in organoid culture leads to significant sample variability and high costs, hindering high-throughput drug screening applications [1] Group 1 - A single technical pathway is insufficient to address systemic issues in organoid research; a cross-platform, multidimensional technical collaboration is necessary to create an integrated solution from model establishment to standardized culture and deep functional characterization [2] - Agilent, in collaboration with Instrument Information Network, will host a webinar on January 21, 2026, titled "Multidimensional Technological Innovation and New Paradigms in Organoid Research," inviting leading scholars and technical experts to discuss pathways for standardized organoid research [2] Group 2 - The agenda for the webinar includes presentations from distinguished guests, such as: - "Construction of Functional Organs Based on Organoid Assembly and Precision Medicine Research" by Dr. Pang Yuan from Tsinghua University [6] - "Instantaneous Dynamics of Organoid Metabolism: Standardized Application of Seahorse XF in 3D Models" by Wei Yufeng from Agilent Technologies (China) [7] - "Multi-modal Automation Platform Compatible with Phenotype and Viability Analysis to Assist in Standardized Organoid Model Establishment" by Yang Jingzhe from Agilent Technologies (China) [7] - "Construction and Application of Engineered Multi-organ Chips: From Absorption Metabolism to Tumor Immune Regulation" by Liu Dongdong from the Chinese Academy of Sciences [7]